Copyright
©The Author(s) 2023.
World J Diabetes. Sep 15, 2023; 14(9): 1369-1384
Published online Sep 15, 2023. doi: 10.4239/wjd.v14.i9.1369
Published online Sep 15, 2023. doi: 10.4239/wjd.v14.i9.1369
Figure 6 Knockdown of XB130 attenuated hyperglycemia-induced inhibitory effects on proliferation and tubule formation of human umbilical vein endothelial cells.
A: Western blot analysis of XB130 protein expression in human umbilical vein endothelial cells; B: Quantification of Western blot results; C: Immunofluorescence staining of Bax, cleaved caspase-3, PCNA, Ki67, and Bcl2 in each group; D: Wound healing assay in each group, scale bars = 200 μm; E: Capillary-like tubule formation, scale bars = 200 μm. aP < 0.001, compared to the high glucose group; bP < 0.001, compared to the HG + Vector group.
- Citation: Zhu XL, Hu DY, Zeng ZX, Jiang WW, Chen TY, Chen TC, Liao WQ, Lei WZ, Fang WJ, Pan WH. XB130 inhibits healing of diabetic skin ulcers through the PI3K/Akt signalling pathway. World J Diabetes 2023; 14(9): 1369-1384
- URL: https://www.wjgnet.com/1948-9358/full/v14/i9/1369.htm
- DOI: https://dx.doi.org/10.4239/wjd.v14.i9.1369